Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Global Cardiovascular Innovation Center (GCIC) is a premier cardiovascular-focused incubator and product development consortium headquartered in Cleveland, Ohio. Launched in 2007 through a $60 million grant from the Ohio Third Frontier program, the center is led by the Cleveland Clinic in partnership with leading academic and clinical institutions across Ohio. GCIC provides early-stage companies with specialized laboratory space, commercialization grants, and comprehensive business development support to accelerate the transition of cardiovascular technologies from the lab to the market. The center has supported over 50 technologies and numerous spinoff companies, including successful exits such as Cleveland HeartLab and CardioInsight. It remains a critical hub within the Cleveland Clinic Innovations ecosystem, fostering advancements in medical devices, diagnostics, and therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Cardiovascular Innovation Center.